Blood test guides stronger combo therapy for advanced lung cancer
Disease control
Recruiting now
This study is for people with stage III non-small cell lung cancer that cannot be removed by surgery. Researchers want to see if adding another immunotherapy drug (tremelimumab) and extra chemotherapy to the standard drug (durvalumab) can lower the amount of cancer DNA found in t…
Phase: PHASE3 • Sponsor: Maximilian Diehn • Aim: Disease control
Last updated May 09, 2026 04:35 UTC